Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)

被引：0
|
作者：
Mayada Saad Farrag
Khaled Abdelwahab
Nesrine Saad Farrag
Waleed Elsayed Elrefaie
Ziad Emarah
机构：
[1] Port Said University,Department of Pathology, Faculty of Medicine
[2] Mansoura University,Department of Surgical Oncology, Mansoura Oncology Center
[3] Mansoura University,Department of Community Medicine and Public Health, Faculty of Medicine
[4] Port Said University,Department of Obstetrics and Gynecology, Port Said Faculty of Medicine
[5] Mansoura University,Department of Medical Oncology, Mansoura Oncology Center
来源：
Journal of the Egyptian National Cancer Institute | / 33卷
关键词：
CD8; HGSC; Immunotherapy; PD-L1; TILs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Farrag, Mayada Saad
    Abdelwahab, Khaled
    Farrag, Nesrine Saad
    Elrefaie, Waleed Elsayed
    Emarah, Ziad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2021, 33 (01)
  • [2] Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
    Hamanishi, Junzo
    Mandai, Masaki
    Iwasaki, Masashi
    Okazaki, Taku
    Tanaka, Yoshimasa
    Yamaguchi, Ken
    Higuchi, Toshihiro
    Yagi, Haruhiko
    Takakura, Kenji
    Minato, Nagahiro
    Honjo, Tasuku
    Fujii, Shingo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) : 3360 - 3365
  • [3] CD3+and CD8+tumor-infiltrating lymphocytes (TILs) as markers of improved prognosis in high-grade serous ovarian cancer
    Kahn, R. M.
    Matrai, C.
    Quinn, A. S.
    Talukdar, N.
    McIntire, P.
    Cubillos-Ruiz, J. R.
    Frey, M. K.
    Caputo, T. A.
    Holcomb, K. M.
    Chapman-Davis, E.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 68 - 68
  • [4] IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Park, Junsik
    Kim, Jung Chul
    Lee, Mi-Ran
    Lee, Joohyang
    Kim, Sunghoon
    Kim, Sang Wun
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A28 - A29
  • [5] PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Strickland, Amanda L.
    Castrillon, Diego H.
    Carrick, Kelley
    Jiang, Qingping
    Niu, Shuang
    Rivera-Colon, Glorimar
    Gwin, Katja
    Hinson, Stacy
    Lea, Jayanthi
    Miller, David S.
    Zheng, Wenxin
    Lucas, Elena
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (08) : 1050 - 1060
  • [6] Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis
    Tao Zhang
    Xin Zhou
    Xiaofei Zhang
    Shuang Niu
    Hao Chen
    Feng Zhou
    Virchows Archiv, 2023, 482 : 755 - 766
  • [7] Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance
    Mondal, Santosh Kumar
    Bhattacharya, Saptarshi
    Sarkar, Aditya Prasad
    Saha, Rama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S81 - S86
  • [8] Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
    Goode, Ellen L.
    Block, Matthew S.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Chen, Wenqian
    Fogarty, Zachary C.
    Gentry-Maharaj, Aleksandra
    Toloczko, Aleksandra
    Hein, Alexander
    Bouligny, Aliecia L.
    Jensen, Allan
    Osorio, Ana
    Hartkopf, Andreas D.
    Ryan, Andy
    Chudecka-Glaz, Anita
    Magliocco, Anthony M.
    Hartmann, Arndt
    Jung, Audrey Y.
    Gao, Bo
    Hernandez, Brenda Y.
    Fridley, Brooke L.
    McCauley, Bryan M.
    Kennedy, Catherine J.
    Wang, Chen
    Karpinskyj, Chloe
    de Sousa, Christiani B.
    Tiezzi, Daniel G.
    Wachter, David L.
    Herpel, Esther
    Taran, Florin Andrei
    Modugno, Francesmary
    Nelson, Gregg
    Lubinski, Jan
    Menkiszak, Janusz
    Alsop, Jennifer
    Lester, Jenny
    Garcia-Donas, Jesus
    Nation, Jill
    Hung, Jillian
    Palacios, Jose
    Rothstein, Joseph H.
    Kelley, Joseph L.
    de Andrade, Jurandyr M.
    Robles-Diaz, Luis
    Intermaggio, Maria P.
    Widschwendter, Martin
    Beckmann, Matthias W.
    Ruebner, Matthias
    Jimenez-Linan, Mercedes
    Singh, Naveena
    JAMA ONCOLOGY, 2017, 3 (12)
  • [9] Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
    Dai, Danian
    Liu, Lili
    Huang, He
    Chen, Shangqiu
    Chen, Bo
    Cao, Junya
    Luo, Xiaolin
    Wang, Feng
    Luo, Rongzhen
    Liu, Jihong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas
    Machuca-Aguado, Jesus
    Conde-Martin, Antonio Felix
    Alvarez-Munoz, Alejandro
    Rodriguez-Zarco, Enrique
    Polo-Velasco, Alfredo
    Rueda-Ramos, Antonio
    Rendon-Garcia, Rosa
    Rios-Martin, Juan Jose
    Idoate, Miguel A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
12345